Sunday 22 Dec, 2024 02:07 PM
Site map | Locate Us | Login
   Can Fin Homes CFO Apurav Agarwal resigns    Auro Pharma gets UK MHRA nod for cancer drug    Reliance Inds arm to acquire 45% stake in Health Alliance Group    Mazagon Dock Shipbuilders delivers two warships to Indian Navy    Dalmia Bharat's president Rajiv Bansal resigns    Cupid bags order worth Rs 18-cr from UNFPA    NTPC Green inks MoU with Govt of Bihar    IDBI Bank board to mull fund-raising proposal on Dec 31    NRB Industrial Bearings CFO Gulestan Kolah resigns    Shilpa Medicare gets GMP certification for Hyderabad Facility    Siemens Ltd leads losers in 'A' group    Restaurant Brands Asia to raise Rs 500 crore via QIP    NBCC bags orders worth Rs 298 cr for healthcare infrastructure projects    Tantia Constructions Ltd leads losers in 'B' group    Volumes soar at Aegis Logistics Ltd counter 
Saravan Stocks
       
Company News
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd gains for third straight session
Dec 20,2024   Hrs IST

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 1356.8, up 2.35% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.76% on the day, quoting at 23768.69921875. The Sensex is at 78513.49, down 0.89%. Dr Reddys Laboratories Ltd has gained around 13.51% in last one month.

Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has gained around 4.3% in last one month and is currently quoting at 22697.9, down 0.1% on the day. The volume in the stock stood at 46.46 lakh shares today, compared to the daily average of 22.23 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1350.35, up 2.44% on the day. Dr Reddys Laboratories Ltd is up 22.14% in last one year as compared to a 11.83% jump in NIFTY and a 39.64% jump in the Nifty Pharma index.

The PE of the stock is 23 based on TTM earnings ending September 24.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37684309
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd